Therapeutic potential of FtsZ inhibition: A patent perspective

Expert Opinion on Therapeutic Patents

Volumn 21, Issue 5, 2011, Pages 657-679

  Awasthi, Divya ^a   Kumar, Kunal ^a   Ojima, Iwao ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Antibacterial agent; bacterial cell division; broad spectrum antimicrobial; FtsZ; MRSA; tuberculosis

Indexed keywords

2 ALKOXYCARBONYLAMINOPYRIDINE DERIVATIVE; 2 CARBAMOYL PTERIDINE; 2''' HYDROXY 5'' BENZYLISOUVARINOL B; 3 [5 [4 OXO 2 THIOXO 3 (3 TRIFLUOROMETHYLPHENYL)THIAZOLIDIN 5 YLIDENEMETHYL] FURAN 2 YL]BENZOIC ACID; 534F6; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BENZIMIDAZOLE DERIVATIVE; BENZO[C]PHENANTHRIDINE DERIVATIVE; DICHAMANETIN; FILAMENTOUS TEMPERATURE SENSITIVE MUTANT Z; FLAVANONE DERIVATIVE; GUANOSINE TRIPHOSPHATE; PC 190723; SANGUINARINE; SB P1G8; SB P3G2; SB P3G5; SB P5C1; SB P8B2; SB P8B4; SB RA 2001; SB RA 5001; SB RA 5012; SRI 3072; SRI 7614; TAXANE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRIDITOXIN; ZANTRIN DERIVATIVE;

BACTERIUM; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PATENT; PROTEIN FUNCTION; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BENZIMIDAZOLES; CELL DIVISION; CYTOSKELETAL PROTEINS; FLAVANONES; GTP PHOSPHOHYDROLASES; GUANOSINE TRIPHOSPHATE; PATENTS AS TOPIC; TAXOIDS;

EID: 79955120811     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.2011.568483     Document Type: Review

References (142)

1. Bloom BR, Murray CJ. Tuberculosis: commentary on a reemergent killer. Science 1992;257(5073):1055-64
2. World Health Organization, Tuberculosis: Data and Country Profiles. Available from: publications/global-report/2010/en/index.html. [Last accessed November 2010]
3. Leavis HL, Willems RJL, Top J, et al. Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerg Infect Dis 2003;9:1108-15 (Pubitemid 37071553)
4. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant staphylococcus aureus infections in the United States. J Am Med Assoc 2007;298(15):1763-71 (Pubitemid 47598444)
5. Loffler CA, MacDougall C. Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections. Exp Rev Anti Infect Ther 2007;5(6):961-81 (Pubitemid 350303027)
6. Maltezou HC, Giamarellou H. Community-acquired methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents 2006;27(2):87-96 (Pubitemid 43138839)
7. Warren DK, Nitin A, Hill C, et al. Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2004;25(2):99-104 (Pubitemid 38252336)
8. Furuno JP, Perencevich EN, Johnson JA, et al. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci co-colonization. Emerg Infect Dis 2005;11(10):1539-44 (Pubitemid 41384339)
9. Sigurdardottir B, Berg JV, Hu J, et al. Descriptive epidemiology and case-control study of patients colonized with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2006;27(9):913-19 (Pubitemid 44449248)
10. Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001;358:207-8 (Pubitemid 32718546)
11. Lentino JR, Narita M, Yu VL. New antimicrobial agents as therapy for resistant gram-positive cocci. Eur J Clin Microbiol Infect Dis 2008;27(1):3-15 (Pubitemid 350197870)
12. Wang J, Soisson SM, Young K, et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 2006;441:358-61 (Pubitemid 44050201)
13. Habich D, Nussbaum FV. Platensimycin, a new antibiotic and "superbug challenger" from nature. ChemMedChem 2006;1:951-4 (Pubitemid 44448792)
14. Ryan KJ, Ray CG. Sherris medical microbiology: an introduction to infectious diseases. McGraw Hill; 2004
15. Oyston PCF, Sjoestedt A, Titball RW. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2004;2(12):967-78 (Pubitemid 39562535)
16. "Tularemia: FAQ About Tularemia". CDC. Available from: . gov/tularemia/Tul-Fact.html. [Last accessed December 2010]
17. Enderlin G, Morales L, Jacobs RF, et al. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 1994;19(1):42-7 (Pubitemid 24227033)
18. Morelli G, Song Y-J, Mazzoni CJ, et al. Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet 2010;42(12):1140-3
19. "Plague: FAQ about Plague". CDC. Available from: agent/plague/faq.asp. [Last Accessed December 2010]
20. Dennis DT, Gage KL, Gratz N, et al. Plague manual: World Health Organization. Geneva, Switzerland; 1999. p. 172
21. Meyer KF. Modern therapy of plague. J Am Med Assoc 1950;144(12):982-5
22. Wagle PM. Recent advances in the treatment of bubonic plague. Indian J Med Sci 1948;2:489-94
23. Hotez PJ, Molyneuz DH, Fenwick A, et al. Control of neglected tropical diseases. N Engl J Med 2007;357(10):1018-27 (Pubitemid 47367081)
24. Miller JR, Waldrop GL. Discovery of novel antibacterials. Expert Opin Drug Discov 2010;5(2):145-54
25. Vollmer W. The prokaryotic cytoskeleton: a putative target for inhibitors and antibiotics? Appl Microbiol Biotechnol 2006;73(1):37-47 (Pubitemid 44627722)
26. Margalit DN, Romberg L, Mets RB, et al. Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality. Proc Natl Acad Sci USA 2004;101(32):11821-6 (Pubitemid 39095378)
27. Ben-Yehuda S, Losick R. Asymmetric cell division in B. subtilis involves a spiral-like intermediate of the cytokinetic protein FtsZ. Cell 2002;109(2):257-66 (Pubitemid 34518263)
28. Goehring NW, Beckwith J. Diverse paths to midcell: assembly of the bacterial cell division machinery. Curr Biol 2005;15(13):R514-R26 (Pubitemid 40950512)
29. Leung AKW, White EL, Ross LJ, et al. Structure of mycobacterium tuberculosis FtsZ reveals unexpected, G Protein-like conformational switches. J Mol Biol 2004;342(3):953-70 (Pubitemid 39165661)
30. Moller-Jensen J, Loewe J. Increasing complexity of the bacterial cytoskeleton. Curr Opin Cell Biol 2005;17(1):75-81 (Pubitemid 40138091)
31. Thanedar S, Margolin W. FtsZ exhibits rapid movement and oscillation waves in helix-like patterns in Escherichia coli. Curr Biol 2004;14(13):1167-73 (Pubitemid 38893979)
32. de Boer P, Crossley R, Rothfield L. The essential bacterial cell-division protein FtsZ is a GTPase. Nature 1992;359(6392):254-6
33. RayChaudhuri D, Park JT. Escherichia coli cell-division gene ftsZ encodes a novel GTP-binding protein. Nature 1992;359(6392):251-4
34. Adams DW, Errington J. Bacterial cell division: assembly, maintenance and disassembly of the Z ring. Nat Rev Microbiol 2009;7(9):642-53
35. Erickson Harold P, Anderson David E, Osawa M. FtsZ in bacterial cytokinesis: cytoskeleton and force generator all in one. Microbiol Mol Biol Rev 2010;74(4):504-28
36. Errington J, Daniel RA, Scheffers D-J. Cytokinesis in bacteria. Microbiol Mol Biol Rev 2003;67(1):52-65 (Pubitemid 36314784)
37. Respicio L, Nair PA, Huang Q, et al. Characterizing septum inhibition in Mycobacterium tuberculosis for noveldrug discovery. Tuberculosis 2008;88(5):420-9
38. Slayden RA, Knudson DL, Belisle JT. Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis. Microbiology 2006;152(6):1789-97
39. Lock RL, Harry EJ. Cell-division inhibitors: new insights for future antibiotics. Nat Rev Drug Discov 2008;7(4):324-38
40. Margolin W. Themes and variations in prokaryotic cell division. FEMS Microbiol Rev 2000;24(4):531-48
41. Rothfield L, Justice S, Garcia-Lara J. Bacterial cell division. Annu Rev Genet 1999;33:423-48 (Pubitemid 30083129)
42. Haydon DJ, Stokes NR, Ure R, et al. An inhibitor of FtsZ with potent and selective anti-staphylococcal activity. Science 2008;321(5896):1673-5
43. Kumar K, Awasthi D, Berger WT, et al. Discovery of anti-TB agents that target the cell-division protein FtsZ. Future Med Chem 2010;2(8):1305-23
44. Kapoor S, Panda D. Targeting FtsZ for antibacterial therapy: a promising avenue. Expert Opin Ther Targets 2009;13(9):1037-51
45. Huang Q, Tonge Peter J, Slayden Richard A, et al. FtsZ: a novel target for tuberculosis drug discovery. Curr Top Med Chem 2007;7(5):527-43 (Pubitemid 46488292)
46. Erickson HP, Taylor DW, Taylor KA, et al. Bacterial cell division protein FtsZ assembles into protofilament sheets and minirings, structural homologs of tubulin polymers. Proc Natl Acad Sci USA 1996;93(1):519-23 (Pubitemid 26038188)
47. Lowe J, Amos LA. Crystal structure of the bacterial cell-division protein FtsZ. Nature 1998;391(6663):203-6 (Pubitemid 28092483)
48. 2+-induced FtsZ sheets. EMBO J 1999;18(9):2364-71 (Pubitemid 29213270)
49. Mukherjee A, Lutkenhaus J. Dynamic assembly of FtsZ regulated by GTP hydrolysis. EMBO J 1998;17(2):462-9 (Pubitemid 28045487)
50. White EL, Ross LJ, Reynolds RC, et al. Slow polymerization of Mycobacterium tuberculosis FtsZ. J Bacteriol 2000;182(14):4028-34 (Pubitemid 30436565)
51. 2+-mediated GTP-dependent dynamic assembly of bacterial cell division protein FtsZ into asters and polymer networks in vitro. EMBO J 1997;16(17):5455-63 (Pubitemid 27380152)
52. Huang Q, Kirikae F, Kirikae T, et al. Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents. J Med Chem 2006;49(2):463-6 (Pubitemid 43157479)
53. White EL, Suling WJ, Ross LJ, et al. 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ. J Antimicrob Chemother 2002;50(1):111-14 (Pubitemid 34785263)
54. Lappchen T, Hartog Aloysius F, Pinas Victorine A, et al. GTP analogue inhibits polymerization and GTPase activity of the bacterial protein FtsZ without affecting its eukaryotic homologue tubulin. Biochemistry 2005;44(21):7879-84 (Pubitemid 40740771)
55. Nogales E, Downing KH, Amos LA, et al. Tubulin and FtsZ form a distinct family of GTPases. Nat Struct Biol 1998;5(6):451-8 (Pubitemid 28265028)
56. Chen Y, Bjornson K, Redick SD, et al. A rapid fluorescence assay for FtsZ assembly indicates cooperative assembly with a dimer nucleus. Biophys J 2005;88(1):505-14 (Pubitemid 40070696)
57. Dajkovic A, Mukherjee A, Lutkenhaus J. Investigation of regulation of FtsZ assembly by SulA and development of a model for FtsZ polymerization. J Bacteriol 2008;190(7):2513-26 (Pubitemid 351466347)
58. Caplan MR, Erickson HP. Apparent cooperative assembly of the bacterial cell division protein FtsZ demonstrated by isothermal titration calorimetry. J Biol Chem 2003;278(16):13784-8 (Pubitemid 36799915)
59. Romberg L, Simon M, Erickson HP. Polymerization of FtsZ, a bacterial homolog of tubulin. Is assembly cooperative? J Biol Chem 2001;276(15):11743-53 (Pubitemid 33650146)
60. Popp D, Iwasa M, Erickson HP, et al. Suprastructures and dynamic properties of Mycobacterium tuberculosis FtsZ. J Biol Chem 2010;285(15):11281-9
61. Popp D, Narita A, Iwasa M, et al. Molecular mechanism of bundle formation by the bacterial actin ParM. Biochem Biophys Res Commun 2010;391(4):1598-603
62. Li Z, Trimble MJ, Brun YV, et al. The structure of FtsZ filaments in vivo suggests a force-generating role in cell division. EMBO J 2007;26(22):4694-708 (Pubitemid 350126800)
63. Erickson HP. The ftsZ protofilament and attachment of ZipA - structural constraints on the FtsZ power stroke. Curr Opin Cell Biol 2001;13(1):55-60 (Pubitemid 32119293)
64. Pichoff S, Lutkenhaus J. Unique and overlapping roles for ZipA and FtsA in septal ring assembly in Escherichia coli. EMBO J 2002;21(4):685-93 (Pubitemid 34174049)
65. Geissler B, Elraheb D, Margolin W. A gain-of-function mutation in ftsA bypasses the requirement for the essential cell division gene zipA in Escherichia coli. Proc Natl Acad Sci USA 2003;100(7):4197-202 (Pubitemid 36418180)
66. Anderson DE, Gueiros-Filho FJ, Erickson HP. Assembly dynamics of FtsZ rings in Bacillus subtilis and Escherichia coli and effects of FtsZ-regulating proteins. J Bacteriol 2004;186(17):5775-81 (Pubitemid 39128650)
67. Stricker J, Maddox P, Salmon ED, et al. Rapid assembly dynamics of the Escherichia coli FtsZ-ring demonstrated by fluorescence recovery after photobleaching. Proc Natl Acad Sci USA 2002;99(5):3171-5 (Pubitemid 34240604)
68. Romberg L, Levin PA. Assembly dynamics of the bacterial cell division protein FtsZ: poised at the edge of stability. Annu Rev Microbiol 2003;57:125-54, 1 plate (Pubitemid 37392938)
69. Romberg L, Mitchison TJ. Rate-limiting guanosine 5′-triphosphate hydrolysis during nucleotide turnover by FtsZ, a prokaryotic tubulin homologue involved in bacterial cell division. Biochemistry 2004;43(1):282-8 (Pubitemid 38055966)
70. Huecas S, Andreu JM. Polymerization of nucleotide-free, GDP- and GTP-bound cell division protein FtsZ: GDP makes the difference. FEBS Lett 2004;569(1-3):43-8 (Pubitemid 38844590)
71. Lu C, Reedy M, Erickson HP. Straight and curved conformations of FtsZ are regulated by GTP hydrolysis. J Bacteriol 2000;182(1):164-70 (Pubitemid 30004571)
72. Mukherjee A, Saez C, Lutkenhaus J. Assembly of an FtsZ mutant deficient in GTPase activity has implications for FtsZ assembly and the role of the Z ring in cell division. J Bacteriol 2001;183(24):7190-7 (Pubitemid 33121853)
73. Oliva MA, Trambaiolo D, Loewe J. Structural insights into the conformational variability of FtsZ. J Mol Biol 2007;373(5):1229-42 (Pubitemid 47539485)
74. Osawa M, Anderson DE, Erickson HP. Reconstitution of contractile FtsZ rings in liposomes. Science 2008;320(5877):792-4 (Pubitemid 351929627)
75. Yanagisawa M, Imai M, Taniguchi T. Shape deformation of ternary vesicles coupled with phase separation. Phys Rev Lett 2008;100(14):148102/1-/4
76. Zhu TF, Szostak JW. Coupled growth and division of model protocell membranes. J Am Chem Soc 2009;131(15):5705-13
77. Beuria TK, Singh P, Surolia A, et al. Promoting assembly and bundling of FtsZ as a strategy to inhibit bacterial cell division: a new approach for developing novel antibacterial drugs. Biochem J 2009;423(1):61-9
78. National Institute of Immunology, India; Indian Institute of Technology, Bombay. Pharmaceutical composition for therapeutic or prophylactic treatment of bacterial infections and associated diseases. WO2010044103; 2009
79. Southern Research Institute, USA. Antibacterial inhibitors of Ftsz protein. WO2004005472; 2004
80. Reynolds RC, Srivastava S, Ross LJ, et al. A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ. Bioorg Med Chem Lett 2004;14(12):3161-4 (Pubitemid 38624584)
81. University of New York, USA. Anti-tuberculosis taxane compounds for use in drug resistance. US20080081836; 2008
82. The Research Foundation of State University of New York, USA. Preparation of benzimidazoles for treatment of Mycobacterium tuberculosis or Francisella tularensis infection. WO2008130669; 2008
83. Kumar K, Awasthi D, Lee S-Y, et al. Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents. J Med Chem 2010;54(1):374-81
84. Boyne ME, Sullivan TJ, am Ende CW, et al. Targeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitors. Antimicrob Agents Chemother 2007;51(10):3562-7 (Pubitemid 47519344)
85. Slayden RA, Lee RE, Barry CE. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. Mol Microbiol 2000;38(3):514-25
86. Laeppchen T, Pinas VA, Hartog AF, et al. Probing FtsZ and tubulin with C8-substituted GTP analogs reveals differences in their nucleotide binding sites. Chem Biol 2008;15(2):189-99 (Pubitemid 351253617)
87. Michie KA, Lowe J. Dynamic filaments of the bacterial cytoskeleton. Annu Rev Biochem 2006;75:467-92 (Pubitemid 44118040)
88. Oliva MA, Cordell SC, Loewe J. Structural insights into FtsZ protofilament formation. Nat Struct Mol Biol 2004;11(12):1243-50
89. Institute for Molecular Cell Biology, Neth.; Institute of Molecular Chemistry. GTP analogs for inhibiting FtsZ protein (de)polymerization and treating infections. WO2001032187; 2001
90. Godowski KC. Antimicrobial action of sanguinarine. J Clin Dent 1989;1(4):96-101 (Pubitemid 19235665)
91. Beuria TK, Santra MK, Panda D. Sanguinarine blocks cytokinesis in bacteria by inhibiting FtsZ assembly and bundling. Biochemistry 2005;44(50):16584-93 (Pubitemid 41832040)
92. State University of New Jersey, USA; University of Medicine and Dentistry ofNew Jersey. Preparation of benzo[c] phenanthridines as antimicrobial agents. WO2010083436; 2010
93. Anam EM. 2-Hydroxy-3- benzyluvarinol, 2-hydroxy-5′- benzylisouvarinol-A and 2-hydroxy-5′- benzylisouvarinol-B: three novel tetra-C-benzylated flavanones from the root extract of Xylopia africana (Benth.) Oliver (Annonaceae).Indian J Chem B Org Chem Incl Med Chem 1994;33B(10):1009-11
94. Hufford CD, Lasswell WL Jr. Antimicrobial activities of constituents of Uvaria chamae. Lloydia 1978;41(2):156-60
95. Urgaonkar S, La Pierre Henry S, Meir I, et al. Synthesis of antimicrobial natural products targeting FtsZ: (+/-)-dichamanetin and (+/-)-2-hydroxy- 5′-benzylisouvarinol-B. Org Lett 2005;7(25):5609-12 (Pubitemid 43010811)
96. President and Fellows of Harvard College, USA. Synthesis of flavanone inhibitors of FtsZ as antibiotics. WO2007056188; 2007
97. President and Fellows of Harvard College, USA; Trustees of Tufts College. Identification of antimicrobial agents. WO2002094976; 2002
98. President and Fellows of Harvard College, USA; Trustees of Tufts College. In vivo assay for identification of antimicrobial agents. US20030138869; 2003
99. President and Fellows of Harvard College, USA; Trustees of Tufts College. Antimicrobial compound combinations for inhibiting cell division. US20060252114; 2006
100. Mukherjee S, Robinson CA, Howe AG, et al. N-Benzyl-3- sulfonamidopyrrolidines as novel inhibitors of cell division in E. coli. Bioorg Med Chem Lett 2007;17(23):6651-5 (Pubitemid 350026310)
101. Ohashi Y, Chijiiwa Y, Suzuki K, et al. The lethal effect of a benzamide derivative, 3-methoxybenzamide, can be suppressed by mutations within a cell division gene, ftsZ, in Bacillus subtilis. J Bacteriol 1999;181(4):1348-51 (Pubitemid 29119578)
102. Prolysis Ltd, UK. Preparation of substituted benzamides and pyridylamides as antibacterial agents. WO2007107758; 2007
103. Prolysis Ltd, UK. Substituted benzamidines as antibacterial agents. WO2009040507; 2009
104. Andreu JM, Schaffner-Barbero C, Huecas S, et al. The antibacterial cell division inhibitor PC190723 is an FtsZ polymer-stabilizing agent that induces filament assembly and condensation. J Biol Chem 2010;285(19):14239-46
105. Oliva MA, Trambaiolo D, Lowe J. Structural insights into the conformational variability of FtsZ. J Mol Biol 2007;373:1229-42 (Pubitemid 47539485)
106. Haydon DJ, Bennett JM, Brown D, et al. Creating an antibacterial with in vivo efficacy: synthesis and characterization of potent inhibitors of the bacterial cell division protein FtsZ with improved pharmaceuticalproperties. J Med Chem 2010;53(10):3927-36
107. Avi Biopharma, Inc., USA. Antisense antibacterial cell division composition and method. WO2001049775; 2001
108. Avi Biopharma, Inc., USA. Antisense antibacterial oligonucleotides for gene silencing. WO2006085973; 2006
109. Merck & Co., Inc., USA. Fluorescent assay for polymerization of purified bacterial FtsZ cell-division protein and use thereof in screening for FtsZ inhibitors as antibacterial agents. WO2003014343; 2003
110. Wang J, Galgoci A, Kodali S, et al. Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics. J Biol Chem 2003;278(45):44424-8 (Pubitemid 37377193)
111. Trusca D, Scott S, Thompson C, et al. Bacterial SOS checkpoint protein SulA inhibits polymerization of purified FtsZ cell division protein. J Bacteriol 1998;180(15):3946-53 (Pubitemid 28361592)
112. Temasek Life Sciences Laboratory Ltd, Singapore. Method of screening antibacterial drug compounds targeting a specific microbial protein. WO2007149056; 2007
113. Smithkline Beecham Corp., USA. The Streptococcus pneumoniae homolog of the ftsZ gene of Escherichia coli and the development of novel antibiotics. EP899334; 1999
114. Smithkline Beecham Corp., USA. FtsZ self-association into multimeric proteins is required for GTPase activity and can be used to screen for antibacterial compounds. WO2000001801; 2000
115. Sossong TM Jr, Brigham-Burke MR, Hensley P, et al. Self-activation of guanosine triphosphatase activity by oligomerization of the bacterial cell division protein FtsZ. Biochemistry 1999;38(45):14843-50
116. Hale CA, de Boer PA. Direct binding of FtsZ to ZipA, an essential component of the septal ring structure that mediates cell division in E. coli. Cell 1997;88(2):175-85 (Pubitemid 28015866)
117. Hale CA, De Boer PAJ. Recruitment of ZipA to the septal ring of Escherichia coli is dependent on FtsZ and independent of FtsA. J Bacteriol 1999;181(1):167-76 (Pubitemid 29013668)
118. Liu Z, Mukherjee A, Lutkenhaus J. Recruitment of ZipA to the division site by interaction with FtsZ. Mol Microbiol 1999;31(6):1853-61 (Pubitemid 29151283)
119. Mosyak L, Zhang Y, Glasfeld E, et al. The bacterial cell-division protein ZipA and its interaction with an FtsZ fragment revealed by X-ray crystallography. EMBO J 2000;19(13):3179-91 (Pubitemid 30428197)
120. Moy FJ, Glasfeld E, Mosyak L, et al. Solution structure of ZipA, a crucial component of Escherichia coli cell division. Biochemistry 2000;39(31):9146-56 (Pubitemid 30626308)
121. Case Western Reserve University, USA. Screening antimicrobials in a cell-free ZipA protein-FtsZ protein binding system. WO9744481; 1997
122. American Home Products Corp., USA. Solution and crystal structures of ZipA and ZipA complex for use in designing antibiotics against Gram-negative bacteria. WO2001073436; 2001
123. American Home Products Corp., USA; Case Western Reserve University; Wyeth. Characterization of a FtsZ binding site and uses thereof. WO2002010419; 2002
124. Haney SA, Glasfeld E, Hale C, et al. Genetic analysis of the Escherichia coli FtsZ.ZipA interaction in the yeast two-hybrid system. Characterization of FtsZ residues essential for the interactions with ZipA and with FtsA. J Biol Chem 2001;276(15):11980-7
125. Jennings LD. Application of parallel synthesis to the optimization of inhibitors of the ZipA-FtsZ protein-protein interaction. High-Throughput Lead Optim. Drug Discov 2008:85-98
126. Jennings LD, Foreman KW, Rush TS, et al. Combinatorial synthesis of substituted 3-(2-indolyl)piperidines and 2-phenyl indoles as inhibitors of ZipA-FtsZ interaction. [Erratum to document cited in CA141:395374]. Bioorg Med Chem 2005;13(20):5884 (Pubitemid 41247770)
127. Jennings LD, Foreman KW, Rush TS, et al. Combinatorial synthesis of substituted 3-(2-indolyl)piperidines and 2-phenyl indoles as inhibitors of ZipA-FtsZ interaction. Bioorg Med Chem 2004;12(19):5115-31 (Pubitemid 39200614)
128. Jennings LD, Foreman KW, Rush TS, et al. Design and synthesis of indolo[2,3-a]quinolizin-7-one inhibitors of the ZipA-FtsZ interaction. Bioorg Med Chem Lett 2004;14(6):1427-31 (Pubitemid 38299423)
129. Sutherland AG, Alvarez J, Ding W, et al. Structure-based design of carboxybiphenylindole inhibitors of the ZipA-FtsZ interaction. Org Biomol Chem 2003;1(23):4138-40
130. Tsao DHH, Sutherland AG, Jennings LD, et al. Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design. Bioorg Med Chem 2006;14(23):7953-61 (Pubitemid 44584704)
131. Shapiro L. Protein localization and asymmetry in the bacterial cell. Cell 1993;73(5):841-55 (Pubitemid 23165603)
132. Merck and Co., Inc., USA. A novel biochemical interaction in bacteria. WO9635804; 1996
133. Domadia P, Swarup S, Bhunia A, et al. Inhibition of bacterial cell division protein FtsZ by cinnamaldehyde. Biochem Pharmacol 2007;74(6):831-40 (Pubitemid 47212076)
134. Domadia PN, Bhunia A, Sivaraman J, et al. Berberine targets assembly of Escherichia coli cell division protein FtsZ. Biochemistry 2008;47(10):3225-34 (Pubitemid 351364915)
135. Higashitani A, Higashitani N, Horiuchi K. A cell division inhibitor SulA of Escherichia coli directly interacts with FtsZ through GTP hydrolysis. Biochem Biophys Res Commun 1995;209(1):198-204
136. Jaiswal R, Beuria TK, Mohan R, et al. Totarol inhibits bacterial cytokinesis by perturbing the assembly dynamics of FtsZ. Biochemistry 2007;46(14):4211-20 (Pubitemid 46559388)
137. Mukherjee A, Cao C, Lutkenhaus J. Inhibition of FtsZ polymerization by SulA, an inhibitor of septation in Escherichia coli. Proc Natl Acad Sci USA 1998;95(6):2885-90 (Pubitemid 28135824)
138. Mukherjee A, Santra MK, Beuria TK, et al. A natural osmolyte trimethylamine N-oxide promotes assembly and bundling of the bacterial cell division protein, FtsZ and counteracts the denaturing effects of urea. FEBS J 2005;272(11):2760-72 (Pubitemid 40825423)
139. Rai D, Singh JK, Roy N, et al. Curcumin inhibits FtsZ assembly: an attractive mechanism for itsantibacterial activity. Biochem J 2008;410(1):147-55 (Pubitemid 351300334)
140. Sarcina M, Mullineaux CW. Effects of tubulin assembly inhibitors on cell division in prokaryotes in vivo. FEMS Microbiol Lett 2000;191(1):25-9
141. Plaza A, Keffer Jessica L, Bifulco G, et al. Chrysophaentins A-H, antibacterial bisdiarylbutene macrocycles that inhibit the bacterial cell division protein FtsZ. J Am Chem Soc 2010;132(26):9069-77
142. Kanoh K, Adachi K, Matsuda S, et al. New sulfoalkylresorcinol from marine-derived fungus, Zygosporium sp. KNC52. J Antibiot 2008;61(3):192-4